| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 09/12/2007 | EP1831216A2 Heteroaromatic derivatives useful as anticancer agents |
| 09/12/2007 | EP1831215A1 Pyrido[2,3-d]pyrimidines as anti-inflamatory agents |
| 09/12/2007 | EP1831214A1 A process for preparation of 4-amino-1-isobutyl-1h-imidazo[4,5-c]-quinoline (imiquimod) |
| 09/12/2007 | EP1831210A1 8-aza-bicyclo[3.2.1]octane derivatives with an activity on chemokine ccr5 receptors |
| 09/12/2007 | EP1831199A1 Novel compounds |
| 09/12/2007 | EP1831196A1 Novel hydantoin derivatives as metalloproteinase inhibitors |
| 09/12/2007 | EP1831150A1 Process for the preparation of (2r, 3r)-2-hydroxy-3-amino-3-aryl-propionamide and (2r, 3r)-2-hydroxy-3-amino-3-aryl-propionic acid alkyl ester |
| 09/12/2007 | EP1830880A2 Multi-route administration of immune response modifier compounds |
| 09/12/2007 | EP1453830B1 Pyrazolo-pyridine derivatives as antiherpes agents |
| 09/12/2007 | EP1379239B1 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor |
| 09/12/2007 | EP1272490B1 Sodium salt of an azo derivative of 5-aminosalicylic acid |
| 09/12/2007 | CN101035788A Halogenation of rylen-carboximides with elementary halogen in a two-phase mixture comprising an organic solvent and water, wherein formed hydrogen halide is continuously removable from the organic sol |
| 09/12/2007 | CN101035787A Method for enantioselective preparation of sulphoxide derivatives |
| 09/12/2007 | CN101035786A Pyrrolopyridine derivatives and their use as CRTH2 antagonists |
| 09/12/2007 | CN101035780A Substituted nitrogen-containing six-membered amino-heterocycles as vanilloid-1 receptor antagonists for treating pain |
| 09/12/2007 | CN101035768A Compounds and compositions useful as cathepsin S inhibitors |
| 09/12/2007 | CN100336817C Method of chromatography preparing high purity catharanthine sulphate by continuous medium pressure column |
| 09/11/2007 | US7268232 Androgen receptor modulators and method of treating disease using the same |
| 09/11/2007 | US7268231 Useful as antiproliferative agents, such as anti-cancer agents |
| 09/11/2007 | US7268230 Quinazoline compounds |
| 09/11/2007 | US7268150 2-cyano-4-fluoropyrrolidine derivative or its salt |
| 09/11/2007 | US7268146 (3,4-Dihydro-1H-isoquinolin-2-yl)-[2-methyl-7-(2,4,6-trimethyl-phenyl)-4,5,6,7-tetrahydro-2H-pyrazolo[3,4-b]pyridin-3-yl]-methanone; Corticotropin releasing factor (CRF); stress-related illnesses, mood disorders such as depression, major depressive disorder, single episode depression |
| 09/11/2007 | US7268145 Thiobenzimidazole derivatives |
| 09/11/2007 | US7268143 Isoquinoline derivatives and methods of use thereof |
| 09/11/2007 | US7268133 Cannabinoid receptor ligands and uses thereof |
| 09/11/2007 | US7268127 Azaindoles having serotonin receptor affinity |
| 09/11/2007 | CA2429114C Treatment of premature ejaculation |
| 09/11/2007 | CA2309196C Novel camptothecin derivatives |
| 09/11/2007 | CA2257846C Process for preparing imidazoquinolinamines |
| 09/07/2007 | WO2007100880A1 Cinnoline and quinazoline derivates as phosphodiesterase 10 inhibitors |
| 09/07/2007 | WO2007100670A1 Spiro condensed piperidnes as modulators of muscarinic receptors |
| 09/07/2007 | WO2007100295A1 Novel dual action receptors antagonists (dara) at the ati and eta receptors |
| 09/07/2007 | WO2007099166A1 Pyrazolo-pyridine derivatives active as kinase inhibitors |
| 09/07/2007 | WO2007099059A1 Use of rylenes as markers for liquids |
| 09/07/2007 | WO2007098961A1 4, 5, 6,7-tetrahydrobenzo[b]thiophene derivatives and their use as sigma receptor ligands |
| 09/07/2007 | WO2007098953A1 Pyrazole derivatives as sigma receptor inhibitors |
| 09/07/2007 | WO2007084532A3 Combination therapy with parp inhibitors |
| 09/07/2007 | WO2007082811A3 Tetrabenzodiazadiketoperylene colourants in ir-reflective coatings and plastics |
| 09/07/2007 | WO2007076601B1 Imaging of d2high receptors using radiolabelled (-)- quinpirole and analogs thereof |
| 09/07/2007 | WO2007029156A3 Isoindoledione derivatives as adrenergic receptor antagonists |
| 09/07/2007 | WO2006102500A3 Fluoroquinolonoquinolones and inkjet ink compositions comprising the same |
| 09/07/2007 | CA2644578A1 Novel dual action receptors antagonists (dara) at the ati and eta receptors |
| 09/07/2007 | CA2643320A1 Modulators of muscarinic receptors |
| 09/07/2007 | CA2643107A1 Use of rylenes as markers for liquids |
| 09/07/2007 | CA2643044A1 Cinnoline and quinazoline derivates as phosphodiesterase 10 inhibitors |
| 09/07/2007 | CA2642649A1 Modulators of muscarinic receptors |
| 09/07/2007 | CA2641144A1 Pyrazole derivatives as sigma receptor inhibitors |
| 09/06/2007 | US20070208176 Biphenyl derivatives |
| 09/06/2007 | US20070208166 Tao Kinase Modulators And Method Of Use |
| 09/06/2007 | US20070208053 Fused heterobicyclic kinase inhibitors |
| 09/06/2007 | US20070208051 Novel N-(Alkoxyalkyl) Carbamoyl-Substituted 6-Phenyl-Benzonaphthyridine Derivatives and their Use as Pde 3/4 Inhibitors |
| 09/06/2007 | US20070208049 e.g. 1-(2,6-Difluorobenzyl)-5-(3-Mehthoxyphenyl)-6-Methyl-3-[N-Methyl -N -(2-Pyridylethyl)Aminoethyl]Uracil; anticarcinoganic agent; prostate cancer, benign prostatic hypertrophy, breast cancer and endometriosis |
| 09/06/2007 | US20070208046 such as 4-benzyloxy-1-{4-[2-(dimethylamino)ethoxy]phenyl}-1H-pyridin-2-one, that as antagonists to melanin concentrating hormone receptors, used for treating cardiovascular, nervous system, metabolic, reproductive system, respiratory system and gatrointestinal disorders |
| 09/06/2007 | US20070208044 Compounds and therapeutical use thereof |
| 09/06/2007 | US20070208036 Arylalkanes, arylalkenes and aryl-azaalkanes, pharmaceutical compositions containing these compounds and processes for preparing them |
| 09/06/2007 | US20070208035 Heterocyclic compounds and their use as aldosterone synthase inhibitors |
| 09/06/2007 | US20070208019 Vasculostatic agents and methods of use thereof |
| 09/06/2007 | US20070208007 Amine-Based Compound and Use Thereof |
| 09/06/2007 | US20070208003 Compounds and methods for treating dyslipidemia |
| 09/06/2007 | US20070207997 inhibitors of I kappa B kinase ( IKK-2) 2-amino-9-methyl-9H-pyrido[2,3-b]indole-3-carboxamide, useful for treating inflammatory diseases and cancer |
| 09/05/2007 | EP1829880A2 Derivatives of camptothecin for use in treating cancer |
| 09/05/2007 | EP1829876A1 Nitrogeneous tricyclic compound |
| 09/05/2007 | EP1829875A1 Pyrazole derivatives as sigma receptor inhibitors |
| 09/05/2007 | EP1829874A1 Tricyclic compound and use thereof |
| 09/05/2007 | EP1828200A1 Bi- and tricyclic substituted phenyl methanones as glycine transporter i (glyt-1) inhibitors for the treatment of alzheimer's disease. |
| 09/05/2007 | EP1828188A1 Bridged ring nk1 antagonists |
| 09/05/2007 | EP1828187A2 Crystalline forms of a factor xa inhibitor |
| 09/05/2007 | EP1828186A1 Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as raf kinase inhibitors |
| 09/05/2007 | EP1828185A2 2-pyrimidinyl pyrazolopyridine erbb kinase inhibitors |
| 09/05/2007 | EP1828184A1 [1,2,4]triazolo[4,3-a]pyridine derivatives for the treatment of hyperproliferative diseases |
| 09/05/2007 | EP1828183A1 4- (4- (imidazol-4-yl) pyrimidin-2-ylamino) benzamides as cdk inhibitors |
| 09/05/2007 | EP1828182A2 Therapeutic pyrazolo[3,4-b]pyridines and indazoles |
| 09/05/2007 | EP1828181A2 Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2m3-b]pyrimidin-4-yl-amines as janus kinase inhibitors |
| 09/05/2007 | EP1828180A1 1h-pyrrolo[2,3-beta]pyridines |
| 09/05/2007 | EP1828167A2 Acrylamide derivatives as antibiotic agents |
| 09/05/2007 | EP1827436A2 Inhibitors of akt activity |
| 09/05/2007 | EP1336611B1 Dehalogeno compounds |
| 09/05/2007 | EP1257551B1 Heterocyclic compounds and their use as parp inhibitors |
| 09/05/2007 | CN101031539A Substituted arylalkanoic acid derivatives and use thereof |
| 09/05/2007 | CN101031299A Thienopyridinone compounds and methods of treatment |
| 09/05/2007 | CN101031296A Modulators of muscarinic receptors |
| 09/05/2007 | CN100335483C Double piperazine quaternary ammonium salt compound with analgetic function |
| 09/05/2007 | CN100335482C Method for converting perylen-3,4:9,10-tetracarboxylic acid diimides into a form suitable for use as a fluorescent dye |
| 09/05/2007 | CN100335481C Poly-substituted pyridino-[4,3d] pyramine with antibacterial and herbicide activity and its production thereof |
| 09/05/2007 | CN100335480C New imidazopyrdine derivatives, its preparation method and medicine composition containing same |
| 09/05/2007 | CN100335479C Bicyclic inhibitors of glycogen synthase kinase 3 |
| 09/04/2007 | US7265378 Light emitting diodes |
| 09/04/2007 | US7265144 Mixture with other active materials; controlling glucose metabolism |
| 09/04/2007 | US7265129 Anti-infective biaryl compounds |
| 09/04/2007 | US7265128 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 09/04/2007 | US7265127 Imidazo[1,2-a]pyridine derivatives, especially N-(2-(8-(3-aminocarbonyl-2-pyridyloxy)imidazo[1,2-a]pyrid-3-yl)-1,1-dimethylethyl)-3-(o-isoxazol-3-ylphenoxy)-2-hydroxypropylamine; treating type-2 diabetes and obesity |
| 09/04/2007 | US7265126 2,8-Diazaspiro[4.5]decan-1-one derivatives, e.g., 4-Phenyl-8-(1-phenyl-cyclohexyl)-2,8-diaza-spiro[4.5]decan-1-one; activate NMDA receptors via Glyt-1 inhibition and are used to treat neurological and neuropsychiatric disorders, particularly schizophrenia, cognitive impairment and Alzheimer's disease |
| 09/04/2007 | US7265123 Heterocyclic compounds |
| 09/04/2007 | US7265119 For therapy of nicotine dependency |
| 09/04/2007 | US7265115 Central nervous system-active cholinergic ligands for neuronal nicotinic receptors; Controlling synaptic transmission; selectively controlling neurotransmitter release; a (halopyridazinyl)-3,8-diazabicyclo(3.2.1)octane |
| 09/04/2007 | US7265111 inhibitors of lipolysis, as cardioprotective agents or they may be of value in the therapy of diabetes |
| 09/04/2007 | US7265104 Tetraazabenzo[e]azulene derivatives and analogs thereof |
| 09/04/2007 | US7265102 Substituted pyrazoles |
| 09/04/2007 | US7264891 Stability, efficiency and color purity |
| 08/30/2007 | WO2007098418A1 Compounds having 5-ht6 receptor affinity |